We are twenty percent apart on valuation with a prospective buyer who loves our business but cannot stretch their senior debt any further. Aside from taking on a risky bottom-line earnout, what structural tools can we use to bridge this gap without leaving our cash exposed?
When you and a buyer reach an impasse on valuation, default advice often pushes you toward an earnout tied to post-closing net income or EBITDA. You should routinely reject bottom-line earnouts because the buyer controls the cost structure post-close, making it effortless for them to allocate corporate overhead, management fees, and aggressive hiring to extinguish your payout.
If you need to bridge a valuation gap without surrendering control, deploy structural instruments that protect your downside:
- Top-line revenue earnouts or unit-volume milestones. If the buyer insists on contingent consideration, tie the payout strictly to gross revenue, contracted customer renewals, or specific product units shipped. Revenue cannot be manipulated by post-close accounting allocations or corporate overhead shifting.
- Performance-priced seller notes. Structure a portion of your seller financing with an adjustable interest coupon or a balloon bonus that triggers if the business hits defined operational milestones, such as retaining eighty-five percent of core customer accounts over twelve months.
- Phantom equity or warrants. If the buyer claims your growth projections are speculative, take warrants or synthetic equity units that pay out upon their future recapitalization or secondary sale. This allows you to capture your valuation upside when they exit, without assuming operational liabilities today.
- Retained IP licensing. If your business utilizes proprietary AI tools, workflows, or patents, sell the operating company at the buyer's clearing multiple but retain ownership of the core intellectual property, licensing it back to them on a long-term, royalty-bearing contract.
Creative deal architecture protects your walk-away value while solving the buyer's leverage limitations.
Category: Valuation & Deal Structure